1. Kirchhof P. The future of atrial fibrillation management: integrated care and stratified therapy. Lancet 2017;390:1873–1887.
2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370–2375.
3. Yoshida T, Uchino S, Yokota T, Fujii T, Uezono S, Takinami M. The impact of sustained new-onset atrial fibrillation on mortality and stroke incidence in critically ill patients: a retrospective cohort study. J Crit Care 2018;44:267–272.
5. Arrigo M, Ishihara S, Feliot E, et al. New-onset atrial fibrillation in critically ill patients and its association with mortality: a report from the FROG-ICU study. Int J Cardiol 2018;266:95–99.
7. Reinelt P, Karth GD, Geppert A, Heinz G. Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiological ICU. Intensive Care Med 2001;27:1466–1473.
8. Lip GYH, Banerjee A, Boriani G, et al. Antithrombotic therapy for atrial fibrillation: chest guideline and expert panel report. Chest 2018;154:1121–1201.
9. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation 2019;140:e125–e151.
11. Healthcare Cost and Utilization Project. Overview of the National (Nationwide) Inpatient Sample (NIS) [Internet] Rockville (MD): HCUP, 2019. [cited 2020 Jun 24]. Available from:
https://www.hcup-us.ahrq.gov/nisoverview.jsp
.
13. Ghaferi AA, Osborne NH, Birkmeyer JD, Dimick JB. Hospital characteristics associated with failure to rescue from complications after pancreatectomy. J Am Coll Surg 2010;211:325–330.
14. Lieffers JR, Baracos VE, Winget M, Fassbender K. A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer 2011;117:1957–1965.
18. Chen AY, Sokol SS, Kress JP, Lat I. New-onset atrial fibrillation is an independent predictor of mortality in medical intensive care unit patients. Ann Pharmacother 2015;49:523–527.
19. Seguin P, Signouret T, Laviolle B, Branger B, Malledant Y. Incidence and risk factors of atrial fibrillation in a surgical intensive care unit. Crit Care Med 2004;32:722–726.
20. Seguin P, Laviolle B, Maurice A, Leclercq C, Malledant Y. Atrial fibrillation in trauma patients requiring intensive care. Intensive Care Med 2006;32:398–404.
22. Makrygiannis SS, Margariti A, Rizikou D, et al. Incidence and predictors of new-onset atrial fibrillation in noncardiac intensive care unit patients. J Crit Care 2014;29:697.
27. Taggar JS, Coleman T, Lewis S, Heneghan C, Jones M. Accuracy of methods for diagnosing atrial fibrillation using 12-lead ECG: a systematic review and meta-analysis. Int J Cardiol 2015;184:175–183.
28. Menke A, Rust KF, Fradkin J, Cheng YJ, Cowie CC. Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies. Ann Intern Med 2014;161:328–335.
29. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA 2016;315:2284–2291.
30. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA 2015;314:1021–1029.
31. Kumar N, Khera R, Garg N. Atrial fibrillation associated hospitalizations in patients with end-stage renal disease in the United States, 2003–2012. Heart Rhythm 2016;13:2027–2033.
32. Xiao X, Han H, Wu C, et al. Prevalence of atrial fibrillation in hospital encounters with end-stage COPD on home oxygen: national trends in the United States. Chest 2019;155:918–927.
33. Crawford TC, Oral H. Cardiac arrhythmias: management of atrial fibrillation in the critically ill patient. Crit Care Clin 2007;23:855–872.
34. Makrygiannis SS, Rizikou D, Patsourakos NG, et al. New-onset atrial fibrillation and clinical outcome in non-cardiac intensive care unit patients. Aust Crit Care 2018;31:274–277.
35. Lin MP, Ma J, Weissman JS, Bernard KR, Schuur JD. Hospital-level variation and predictors of admission after ED visits for atrial fibrillation: 2006 to 2011. Am J Emerg Med 2016;34:2094–2100.
37. Duby JJ, Heintz SJ, Bajorek SA, Heintz BH, Durbin-Johnson BP, Cocanour CS. Prevalence and course of atrial fibrillation in critically Ill trauma patients. J Intensive Care Med 2017;32:140–145.
38. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263–272.
39. Gupta S, Tiruvoipati R, Green C. Atrial fibrillation and mortality in critically Ill patients: a retrospective study. Am J Crit Care 2015;24:336–341.
43. Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 2013;310:1683–1691.
45. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet 2009;373:155–166.
46. Klein Klouwenberg PM, Frencken JF, Kuipers S, et al. Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically Ill patients with sepsis: a cohort study. Am J Respir Crit Care Med 2017;195:205–211.
48. Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Iezzoni LI. Identification of in-hospital complications from claims data. Is it valid? Med Care 2000;38:785–795.
49. Carrera P, Thongprayoon C, Cheungpasitporn W, Iyer VN, Moua T. Epidemiology and outcome of new-onset atrial fibrillation in the medical intensive care unit. J Crit Care 2016;36:102–106.